Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.95
CuraScientific Corp.: Reincorporation merger resulted in adoption of CuraScientific's Articles of Incorporation, changing domicile from Oklahoma to Florida (effective 2023-04-17).
- Change
- charter amendment
- Effective
- 2023-04-17
Exact text from the filing
Pursuant to an Agreement and Plan of Merger (“Merger Agreement”), dated as of December 13, 2022, by and between, Boon Industries, Inc., an Oklahoma corporation (“Boon”), and CuraScientific Corp., a Florida corporation and wholly-owned subsidiary of Boon (“CuraScientific”), effective as of April 17, 2023, Boon merged with and into CuraScientific, with CuraScientific being the surviving entity (the “Reincorporation Merger”). The Reincorporation Merger, including the Reverse Stock Split and Name Change described below, were approved by the written consent of stockholders owning a majority of the voting power of Boon’s capital stock, as reported in the Definitive Information Statement on Schedule 14C filed by Boon with the Securities and Exchange Commission on December 19, 2022. Pursuant to the terms of the Merger Agreement and as a result of the effectiveness of the Reincorporation Merger: ● Boon merged with and into CuraScientific, with CuraScientific being the surviving corporation; ● o
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.95
CuraScientific Corp.: Reincorporation merger resulted in adoption of CuraScientific's Bylaws (effective 2023-04-17).
- Change
- bylaw amendment
- Effective
- 2023-04-17
Exact text from the filing
Pursuant to an Agreement and Plan of Merger (“Merger Agreement”), dated as of December 13, 2022, by and between, Boon Industries, Inc., an Oklahoma corporation (“Boon”), and CuraScientific Corp., a Florida corporation and wholly-owned subsidiary of Boon (“CuraScientific”), effective as of April 17, 2023, Boon merged with and into CuraScientific, with CuraScientific being the surviving entity (the “Reincorporation Merger”). The Reincorporation Merger, including the Reverse Stock Split and Name Change described below, were approved by the written consent of stockholders owning a majority of the voting power of Boon’s capital stock, as reported in the Definitive Information Statement on Schedule 14C filed by Boon with the Securities and Exchange Commission on December 19, 2022. Pursuant to the terms of the Merger Agreement and as a result of the effectiveness of the Reincorporation Merger: ● Boon merged with and into CuraScientific, with CuraScientific being the surviving corporation; ● o
View on SEC.gov